Ruowei Wang
State Key Laboratory Of Oncology In South China, 651 Dongfeng Road East
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Preclinical Pharmacological Evaluation of Sacituzumab Govitecan (IMMU-132) in TROP2-Positive Colorectal Liver Metastasis Models.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 08, 2026
Corrigendum to: Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasis: Cancer Treatment and Research Communications 46 (2026) 101059.
Journal: Cancer treatment and research communications
Published: January 15, 2026
Adjuvant chemo-immunotherapy shows comparable efficacy among mismatch-repair-deficient and mismatch-repair-proficient stage III colon cancer: an exploratory, reconstructed individual patient-level data analysis.
Journal: Journal for immunotherapy of cancer
Published: January 09, 2026
Feedback regulation between histone H3 lysine 18 lactylation and TROP2-mediated glycolysis drives metastatic progression of colorectal cancer.
Journal: Clinical and translational medicine
Published: August 18, 2025
PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation.
Journal: Cancer research
Published: August 07, 2025
Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasis.
Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasis.
Journal: Cancer treatment and research communications
Published: July 01, 2025
Prognostic significance of DNA ploidy, stroma fraction, and nucleotyping in stage IIIb colon cancer and their implications for adjuvant chemotherapy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 25, 2025
Neoadjuvant rectal-tumor regression grade combined score as surrogate endpoint for disease-free survival in locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy.
Journal: The oncologist
Published: December 02, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026